ECOR
electroCore, Inc.NASDAQHealthcare$6.80+3.53%ClosedMarket Cap: $55.0M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
-32.97
P/S
1.78
EV/EBITDA
-5.16
DCF Value
$-460.47
FCF Yield
-14.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
86.8%
Operating Margin
-41.1%
Net Margin
-43.6%
ROE
-2072.1%
ROA
-74.8%
ROIC
-171.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $9.2M | 88.4% | $-2.9M | $-3.0M | $-0.38 | — |
| FY 2025 | $32.0M | 86.8% | $-13.2M | $-14.0M | $-1.65 | — |
| Q3 2025 | $8.7M | 86.0% | $-2.9M | $-3.4M | $-0.40 | — |
| Q2 2025 | $7.4M | 87.3% | $-3.5M | $-3.7M | $-0.44 | — |
| Q1 2025 | $6.7M | 84.9% | $-3.8M | $-3.9M | $-0.47 | — |
| Q4 2024 | $7.0M | 85.9% | $-3.1M | $-3.2M | $-0.43 | — |
| FY 2024 | $25.2M | 85.0% | $-12.2M | $-11.9M | $-1.59 | — |
| Q3 2024 | $6.6M | 83.8% | $-2.7M | $-2.5M | $-0.31 | — |
| Q2 2024 | $6.1M | 86.3% | $-2.6M | $-2.7M | $-0.38 | — |
| Q1 2024 | $5.4M | 83.7% | $-3.8M | $-3.5M | $-0.53 | — |
| Q4 2023 | $5.2M | 78.8% | $-4.0M | $-4.0M | $-0.61 | — |
| FY 2023 | $16.0M | 82.5% | $-18.8M | $-18.8M | $-3.42 | — |